Compare iShares MSCI India ETF (INDA) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI India ETF vs Tempus AI — how do they compare? iShares MSCI India ETF trades at $49.95, while Tempus AI trades at $54.3 (market cap $10.05B). The key difference: iShares MSCI India ETF is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.
| INDA | TEM | |
|---|---|---|
Sector | Broad Market / Factor | Broad Market / Factor |
52-Week High | $55.29 | $103.25 |
52-Week Low | $45.42 | $41.55 |
Market Cap | — | $10.05B |
Enterprise Value | — | $10.68B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INDA trades at $50.04, down 0.2% with a bullish technical signal from moving averages. The ETF reflects India's economic growth at 7.8% (CNBC, 2026-06-05) but faces headwinds from foreign outflows and sector-specific challenges in pharma and IT. Technical indicators show mixed signals with RSI suggesting potential overbought conditions while ADX indicates strong trend strength.
Outlook remains cautiously optimistic given India's strong economic fundamentals, though near-term risks include geopolitical tensions, monsoon uncertainties, and foreign capital rotation away from emerging markets. The ETF offers exposure to the world's fastest-growing large economy but requires monitoring of external pressures.
Tempus AI (TEM) trades at $54.48, down 1.05% today, with a bullish technical signal from moving averages but overbought RSI levels. The company reported a Q2 2026 loss of $0.04 per share, beating estimates, and raised 2026 revenue guidance to $1.4 billion. Recent news highlights growth in oncology testing and AI-driven precision medicine, including the planned acquisition of Personalis to expand minimal residual disease testing capabilities.
Outlook remains positive with 61.5% analyst buy ratings and a $61.57 consensus price target, though risks include persistent net losses, high cash burn from operations, and competitive pressures in AI healthcare. The stock offers upside if execution improves profitability, but investors should monitor cash flow sustainability and integration of acquisitions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares MSCI India ETF
INDA tracks the MSCI India Index, providing broad exposure to large and mid-cap companies in the Indian stock market. It is structurally dominated by the financials, information technology, and energy sectors, serving as a core instrument for investors seeking a single-country view of India's long-term economic growth.
Read more on INDA →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
